Germany: Medical Devices Vetter Increases Secondary Packaging Capabilities
At their Ravensburg site, Vetter packages various syringes, cartridges and vials, some with highly complex requirements on state-of-the-art lines. In addition to the existing area of approximately 6,000 m2, an additional 2,900 m2 will be available in a new building by 2020.
Ravensburg/Germany — Vetter is a solution provider of prefilled drug-delivery systems and a specialist for a wide range of packaging solutions. In addition to labelling, blister packing, cartoning as well as serialization, the company offers its customers further technically sophisticated packaging solutions such as the assembly of pens, auto-injectors and safety devices.
The demand for these systems is continuously increasing. For example, diabetes patients benefit from the ease of handling and exact dosage during application. Vetter includes the production of these complex packaging solutions among its core competencies. Due to its many years of experience and expert knowledge of its staff, the company is at the position to meet the different requirements that authorities, customers and patients demand in a product. Due to the modular use of manual, semi-automatic and fully automatic machines, the company is able to individually package anything from small clinical to large commercial quantities and, therefore, react flexibly to changing customer structures and requirements.
The extension also includes investments in modern testing and analysis methods. In addition to standard release and stability tests, e.g. syringes with a needle shield, the pharmaceutical service provider will be at the position to offer its customers even more extensive tests for autoinjectors beginning in March 2019. This development was achieved through the efforts of a team of specialized engineers that worked on the development of a testing machine, enabling application simulations and digital documentation on auto-injectors. Vetter is setting a new standard for testing machines for autoinjectors in the pharmaceutical industry.